Tea Tree Oil as an Agent for MRSA Decolonization by Kremsreiter, Andrea
Pacific University
CommonKnowledge
School of Physician Assistant Studies Theses, Dissertations and Capstone Projects
Summer 8-12-2016
Tea Tree Oil as an Agent for MRSA
Decolonization
Andrea Kremsreiter
Pacific University
Follow this and additional works at: http://commons.pacificu.edu/pa
Part of the Medicine and Health Sciences Commons
This Capstone Project is brought to you for free and open access by the Theses, Dissertations and Capstone Projects at CommonKnowledge. It has
been accepted for inclusion in School of Physician Assistant Studies by an authorized administrator of CommonKnowledge. For more information,
please contact CommonKnowledge@pacificu.edu.
Recommended Citation
Kremsreiter, Andrea, "Tea Tree Oil as an Agent for MRSA Decolonization" (2016). School of Physician Assistant Studies. Paper 582.
Tea Tree Oil as an Agent for MRSA Decolonization
Abstract
MRSA infections are a significant cause of morbidity and mortality worldwide. Due to concerns about
increasing antibiotic resistance, alternative therapies are being considered to prevent and treat MRSA
infections. Tea tree oil preparations have been shown to have antimicrobial properties, including against
MRSA, in in vitro studies. The purpose of this review is to investigate the effects of topical tea tree oil
preparations as an eradication agent for patients colonized with MRSA.
Degree Type
Capstone Project
First Advisor
Annjanette Sommers
Keywords
MRSA, tea tree oil
Subject Categories
Medicine and Health Sciences
Rights
Terms of use for work posted in CommonKnowledge.
This capstone project is available at CommonKnowledge: http://commons.pacificu.edu/pa/582
Copyright and terms of use
If you have downloaded this document directly from the web or from CommonKnowledge, see the
“Rights” section on the previous page for the terms of use.
If you have received this document through an interlibrary loan/document delivery service, the
following terms of use apply:
Copyright in this work is held by the author(s). You may download or print any portion of this document
for personal use only, or for any use that is allowed by fair use (Title 17, §107 U.S.C.). Except for personal
or fair use, you or your borrowing library may not reproduce, remix, republish, post, transmit, or
distribute this document, or any portion thereof, without the permission of the copyright owner. [Note:
If this document is licensed under a Creative Commons license (see “Rights” on the previous page)
which allows broader usage rights, your use is governed by the terms of that license.]
Inquiries regarding further use of these materials should be addressed to: CommonKnowledge Rights,
Pacific University Library, 2043 College Way, Forest Grove, OR 97116, (503) 352-7209. Email inquiries
may be directed to:. copyright@pacificu.edu
This capstone project is available at CommonKnowledge: http://commons.pacificu.edu/pa/582
 
 
NOTICE TO READERS 
 
This work is not a peer-reviewed publication.  The Master’s Candidate author of this 
work has made every effort to provide accurate information and to rely on authoritative 
sources in the completion of this work.  However, neither the author nor the faculty 
advisor(s) warrants the completeness, accuracy or usefulness of the information provided 
in this work.  This work should not be considered authoritative or comprehensive in and 
of itself and the author and advisor(s) disclaim all responsibility for the results obtained 
from use of the information contained in this work.  Knowledge and practice change 
constantly, and readers are advised to confirm the information found in this work with 
other more current and/or comprehensive sources. 
 
The student author attests that this work is completely his/her original authorship and that 
no material in this work has been plagiarized, fabricated or incorrectly attributed.         
 
Tea Tree Oil as an Agent for MRSA 
Decolonization 
Andrea Kremsreiter 
A Clinical Graduate Project Submitted to the Faculty of the 
School of Physician Assistant Studies 
Pacific University 
Hillsboro, OR 
For the Masters of Science Degree, August 13, 2016 
Faculty Advisor: Brent Norris, PA-C, MS 
Clinical Graduate Project Coordinator: Annjanette Sommers, PA-C, MS 
2 
Biography 
 [Redacted for privacy] 
3 
Abstract 
Background: MRSA infections are a significant cause of morbidity and mortality 
worldwide. Due to concerns about increasing antibiotic resistance, alternative therapies 
are being considered to prevent and treat MRSA infections. Tea tree oil preparations have 
been shown to have antimicrobial properties, including against MRSA, in in vitro studies. 
The purpose of this review is to investigate the effects of topical tea tree oil preparations 
as an eradication agent for patients colonized with MRSA.  
Methods:  An exhaustive online medical literature search was conducted using 
MEDLINE-Ovid, Web of Science, and CINAHL using the keywords: MRSA and tea tree 
oil. Eligible studies were assessed using the GRADE system. 
Results: Two randomized controlled trials met inclusion criteria for this systematic 
review. One RCT (N=224) found that tea tree oil preparations were effective as MRSA 
eradication regimens, although slightly less effective than the routine treatment regimen.. 
Another study (N=30) found that topical tea tree oil preparations were more effective 
than routine treatment regimens in decolonizing patients with MRSA, although the results 
were not statistically significant due to small patient sample size.   
Conclusion: Tea tree oil has been shown to have activity against MRSA both in vivo and 
in vitro. However, studies investigating the use of tea tree oil as agent for MRSA 
decolonization do not provide strong enough evidence for its induction into universally 
used treatment regimens. Tea tree oil is safe and well tolerated by patients and can be 
considered as an alternative agent to eradicate MRSA from patients who are unable or 
unwilling to follow current standard of care treatment regimens.  
Keywords:  MRSA, tea tree oil 
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Tea Tree Oil as an Agent for Decolonization of MRSA 
BACKGROUND 
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen 
causing considerable morbidity and mortality worldwide. A 2011 report from the United 
States Center for Disease Control (CDC) estimates that there were 80 461 invasive 
MRSA infections and 11 285 MRSA related deaths annually.1 These numbers, coupled 
with concerns about increasing antibiotic resistance, have led researchers to consider 
alternative agents including plant derived oils, like tea tree oil, in the fight against 
MRSA. 
Staphylococcus spp. are common colonizers of human skin. Of those species, S. 
aureus is the most virulent.2 S. aureus can cause skin and soft tissue infections, such as 
furuncles, but can also cause more invasive illnesses such as osteomyelitis, pneumonia, 
urinary tract infections, bacteremia, and sepsis which can lead to death.1 It is estimated 
that 10-30% of the general population carries S. aureus in the anterior nares2 and 7% of 
US hospital patients are colonized with MRSA.3 Many carriers are asymptomatic but are 
at a higher risk of invasive infection due to autoinoculation. These carriers many also 
unknowingly spread the bacteria to those they are in direct contact with. Moreover, S. 
aureus can survive periods of drying.2 As such, people are at risk of colonization if they 
come in contact with contaminated fomites.  
Strains of S. aureus developed resistance to methicillin shortly after its induction in 
use in the 1960s.4 The term MRSA is now used to describe strains of S. aureus that are 
resistant to beta lactam antibiotics, including methicillin, oxacillin, nafcillin, and 
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dicloxacillin, as well as cephalosporins.2 It is this continuously developing antibiotic 
resistance that makes MRSA a public health threat worldwide. 
Healthcare-associated MRSA (HA-MRSA) is a particularly heavy burden for both 
patients and the healthcare system alike. A meta-analysis found patients with HA-MRSA 
bacteremia had a twofold greater risk of death compared to patients with healthcare-
associated methicillin susceptible S. aureus (HA-MSSA) bacteremia.5 Further studies 
have concluded that patients infected with MRSA require longer intensive care stays and 
have increased ventilator dependency.6 In addition to increased patient morbidity and 
mortality, HA-MRSA infections are of concern due to the financial burden it places on 
healthcare systems. Patients afflicted with MRSA bacteremia have a 1.29 fold increase in 
length of hospitalization and a 1.36 fold increase in hospital charges compared to patients 
with MSSA bacteremia.7  
The increasing concern about antibiotic resistance has cultivated interest in the use of 
complementary medicines, such as plant-derived oils like tea tree oil. Tea tree oil is a 
volatile essential oil produced by the Australian plant Melaleuca alternifolia. Tea tree oil 
has been shown to have a number of antimicrobial effects in vitro, which are mainly 
attributed to the compound terpinen-4-ol.8 This in vitro research has led some to consider 
its application as an agent for the eradication of MRSA in patients colonized with the 
pathogen. 
The intent of this review is to determine whether tea tree oil products can be used as 
an effective means for decolonizing MRSA carriers. Due to the very serious threat 
antibiotic resistant organisms place on public health, new drugs and treatments must be 
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sought if we wish to prevent transmission and improve associated morbidity and 
mortality.  
METHODS 
An exhaustive literature search using MEDLINE-Ovid, Web of Science, and 
CINAHL was performed and used the following search terms: “MRSA” and “tea tree 
oil.” Inclusion/exclusion criteria was applied. Included were human studies evaluating tea 
tree oil as an agent for MRSA decolonization compared to standard of care 
decolonization regimens. Studies focusing on tea tree oil as an agent of decolonization of 
MRSA wounds were further excluded, as the purpose of this review is to evaluate its 
effect on the carriage of MRSA. Studies were excluded if they were not published in the 
English language. Studies meeting these eligibility criteria were analyzed for quality 
using the Grading of Recommendations, Assessment, Development, and Evaluation 
(GRADE) system.9  
RESULTS 
The initial search of the abovementioned databases yielded 78 articles for review. 
After applying the eligibility criteria, two relevant articles were identified. These articles 
are randomized controlled trials assessing the use of tea tree oil as a decolonization agent 
for MRSA.10,11 See Table I.  
Dryden et al 
 Dryden et al10 published their randomized controlled trial evaluating the 
application of tea tree oil in the eradication of MRSA colonization. Patients at the 
participating hospital who were colonized with MRSA were considered for this study. 
Those excluded from the study included patients unable to give informed consent, 
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sensitive to tea tree oil, under the age of 16, pregnant, or breastfeeding. Two hundred 
thirty six patients were enrolled in the study, but 12 were lost to follow-up. Thus, 224 
patients were evaluated. Study participants were randomly allocated to receive routine 
care or intervention care.10 
The routine care regimen was defined by Dryden et al as mupirocin 2% nasal 
ointment applied to the anterior nares three times a day for five days, chlorhexidine 
gluconate 4% soap applied all over the body at least once a day for five days, silver 
sulfadiazine 1% cream to skin lesions, wounds, leg ulcers once a day for five days.10 
The intervention care regimen was defined by Dryden et al as tea tree 10% cream 
applied to the anterior nostrils three times a day for five days; tea tree 5% body wash all 
over the body at least once a day for five days; tea tree 10% cream to skin lesions, 
wounds and ulcers, and also to axillae or groins as an alternative to the body wash.10 
MRSA detection was accomplished with swabs of the nose, throat, axillae, groin 
creases, and open skin lesions prior to treatment, day 2 post treatment, and day 14 post 
treatment. Positive detection of MRSA in any site was defined as failure to clear 
MRSA.10 
Upon completion of the trial, 56 (49%) patients in the routine care group and 46 
(41%) patients in the tea tree oil treatment group were decolonized of MRSA. No 
significant difference between treatment regimens was present (P=0.0286 Fisher’s exact 
test).10 
The effects of the respective treatment regimens on nasal carriage were analyzed 
separately. Dryden et al determined that mupirocin 2% nasal ointment is significantly 
more effective at clearing nasal carriage of MRSA than tea tree 10% cream (P=0.0001 
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Fisher’s exact test). Fifty eight (78%) of the 74 routine care patients with nasal MRSA 
colonization were cleared with the mupirocin treatment. Thirty six (47.3%) of the 76 tea 
tree oil intervention patients with nasal MRSA colonization were cleared with the tea tree 
cream treatment.10  
Caelli et al 
 This randomized controlled trial was undertaken as a pilot study to determine the 
efficacy of tea tree oil in the decolonization of MRSA.11 In this study, 30 adult inpatients 
either infected or colonized with MRSA were randomly allocated to receive routine care 
or intervention care. Routine care was defined as 2% mupirocin nasal ointment and 
triclosan bodywash. Intervention care was defined as 4% tea tree oil nasal ointment and 
5% tea tree oil body wash. IV vancomycin was administered to all infected patients. 
Study participants were instructed to follow their prescribed regimen for a minimum of 
three days. Screening samples were obtained at 48 and 96 hours post completion of the 
treatment regimen from patients’ nares, perianal region, and any site known to be 
previously MRSA positive.11 
 In this study, the tea tree oil intervention was more effective in clearing MRSA 
than the routine care regimen. Five patients (33%) in the tea tree oil treatment group were 
cleared of MRSA compared to two patients (13%) in the routine care regimen. Due to the 
limited size of this study, these results do not indicate a significant difference in 
outcomes. Seven patients (47%) in the tea tree oil treatment group and 5 patients (33%) 
in the routine care regimen failed to complete this trial for unspecified reasons.11  
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DISCUSSION 
 Increasing resistance to current antibiotics has led to the consideration of 
alternative therapies to control and prevent MRSA infections. In vitro studies have 
demonstrated the bactericidal activity of tea tree oil against MRSA. The next step in 
identifying the utility of tea tree oil as an agent for decolonization of MRSA would be in 
vivo human randomized controlled trials. This review analyzed two such randomized 
controlled trials.10,11 Although the overall quality of these two studies is low (see Table 
II), there is some evidence of efficacy of tea tree oil as an agent for decolonization of 
MRSA and further studies are warranted. 
Limitations of Study – Dryden et al 
 Dryden et al10 published a randomized controlled trial comparing a tea tree oil 
intervention regimen with a routine care treatment regimen as described above. This 
study had some limitations that should be kept in consideration when analyzing the 
outcomes. This study had an adequate sample size and well-described, comparable 
treatment regimens. However, compliance to the treatment regimen was not closely 
monitored and relied on nursing staff and patients to report any problems with delivery of 
the treatment regimen.  
Limitations of Study – Caelli et al 
 The randomized controlled trial published by Caelli et al11 determined that 4% tea 
tree nasal ointment and 5% tea tree body wash was more effective at eradicating MRSA 
than the routine care regimen of 2% mupirocin nasal ointment and triclosan body wash. 
However, the population size (N=30) was inadequate to determine statistical significance. 
Further lowering this quality of evidence was significant loss to follow-up. Seven patients 
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(47%) in the tea tree oil treatment group and 5 patients (33%) in the routine care regimen 
failed to complete this trial for unspecified reasons. It is unclear whether blinding was 
utilized for this study, but because discrete endpoints (eradication of MRSA) were used, 
this does not greatly impact the quality of evidence. Also of note, this study was 
sponsored in part by Australian Bodycare Pty Ltd; this company manufactured the tea 
tree oil products used in the study. Because the endpoints of the study are discrete, the 
risk of bias from this factor is limited and of little concern. Further aspects to consider 
when evaluating the quality of evidence from this study include the disparity in treatment 
days. All patients were instructed to use their prescribed treatment regimen for a 
minimum of three days, but the endpoint varies considerably. The average number of 
treatment days in the routine care group was 5.6 days (range = 2-14). The average 
number of treatment days in the tea tree oil intervention group was 10.7 days (range = 1-
34). Compliance monitoring protocol was omitted from this article.11  
Further discussion 
 Due to the low quality of evidence presented in these studies, tea tree oil 
treatment regimens should not replace the current routine care interventions. However, 
these studies do demonstrate that tea tree oil topical preparations may have similar 
efficacy to routine care regimens in eradicating MRSA colonization. The tea tree oil 
treatment regimens were well tolerated among participants in both studies and no adverse 
reactions were observed.10,11 Based on this evidence, tea tree oil preparations may be 
appropriate for patients unable or unwilling to use routine care regimens (mupirocin, 
triclosan, chlorhexidine gluconate, and/or silver sulfadiazine).  
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 Due to the limitations of these studies, further research is required to establish tea 
tree oil’s place as an agent of decolonization of MRSA. Large scale, randomized 
controlled trials with explicit treatment protocols and compliance monitoring would be 
ideal in order to definitively identify tea tree oil as an agent for the eradication of MRSA 
colonization.  
 Currently mupirocin and chlorhexidine gluconate are the current standard agents 
for MRSA decolonization.12 However, in the United States, MRSA decolonization is not 
routinely recommended in asymptomatic carriers with low risk of transmission due to 
concerns of efficacy and growing antibiotic resistance.13 Studies have demonstrated 
evidence of MRSA strains that have developed resistance to mupirocin14,15 and 
chlorhexidine gluconate.16 These concerns justify further studies on the efficacy of tea 
tree oil as an agent of MRSA decolonization. It is evident that new treatments must be 
sought and established if we wish to quell the onslaught of MRSA carriage and infection. 
CONCLUSION 
Due to the significant burden antimicrobial resistant pathogens place on 
individuals’ health and our healthcare system as a whole, new drugs and therapies must 
be explored and implemented into standards of care. Tea tree oil has been shown to have 
bactericidal activity against MRSA in in vitro studies. This review analyzed data from 
randomized controlled trials conducted in human patients colonized or infected with 
MRSA. Based on the data in those trials, tea tree oil may be considered as an alternative 
agent for the decolonization of MRSA. However, the low quality of evidence in those 
trials necessitates the need for further studies to determine the efficacy of the tea tree oil 
based treatment regimen.  
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Authors Study Design 
Patient 
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of 
Patients 
Average 
patient 
age 
(years) 
Average 
Treatment 
Duration 
(days) 
Outcomes 
Patients 
cleared of 
MRSA 
carriage 
Patient loss 
to follow up 
Caelli et 
al11 
Randomized 
Controlled 
Trial 
Adult 
inpatients 
infected or 
colonized 
with MRSA 
Tea tree oil 
treatment 
regimen 
15 
58 
(range = 
28-82) 
10.7 
(range = 1-
34) 
5 (33%) 7 (47%) 
Routine care 
treatment 
regimen 
15 
74 
(range = 
45-87) 
5.6 
(range = 2-
14) 
2 (13%) 5(33%) 
 
 
  
 
Table I: Summary of Findings 
 
Authors Study Design 
Patient 
Population 
Treatment 
Duration 
(days) 
Group 
Number 
of 
Patients 
Number of 
Patients 
with Nasal 
Carriage 
of MRSA 
Outcomes 
Patients 
cleared of 
MRSA 
carriage 
Patients 
cleared of 
nasal 
carriage of 
MRSA 
Dryden et 
al10 
Randomized 
Controlled 
Trial 
Inpatients 16 
years or older 
infected or 
colonized 
with MRSA 
5 
Tea tree oil 
treatment 
regimen 
110 76 46 (41%) 36 (47.3%) 
Routine care 
treatment 
regimen 
114 74 56 (49%) 58 (78%) 
 P-value   P = 0.0286 P = 0.0001 
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Table II: Quality Assessment of Reviewed Articles 
 
Study Design 
Downgrade Criteria 
Upgrade 
Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision 
Publication 
bias 
Dryden et al10 RCT Seriousa Not Serious Not Serious Not Serious Unlikelyb 
No 
upgrade 
Moderate 
Caelli et al11 RCT 
Very 
Seriousa,c,e 
Not Serious Not Seriousd Seriousc,e Likelyf 
No 
upgrade 
Very 
Low 
aBlinding procedure not mentioned.  
bTea tree oil preparations by Ord River Tea Tree Oil Ptd Ltd. 
cLarge loss to followup. 
dConfidence intervals were not calculated for this article.  
eSmall sample size 
fThis study was sponsored in part by Australian Bodycare Pty Ltd  
